DNA icon

Glycogen Storage Disease Type Ib via the SLC37A4 (G6PT1) Gene

Summary and Pricing

Test Method

Exome Sequencing with CNV Detection
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
SLC37A4 81406 81406,81479 $990
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
9779SLC37A481406 81406,81479 $990 Order Options and Pricing

Pricing Comments

Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information. If the Sanger option is selected, CNV detection may be ordered through Test #600.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).

Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).

The Sanger Sequencing method for this test is NY State approved.

For Sanger Sequencing click here.

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.


Genetic Counselors


  • Maxime Cadieux-Dion, PhD

Clinical Features and Genetics

Clinical Features

Glycogen storage disease type Ib (GSDIb) is caused by a deficiency of glucose-6-phosphate translocase. Symptoms, which appear in the first year of life, are mostly similar to GSDIa and include severe fasting hypoglycemia, massive hepatomegaly, and hyperlactatemia. In addition, patients with GSDIb may also display neutropenia with abnormal monocytes leading to frequent bacterial and fungal infections. Type Ib patients may also have oral and intestinal mucosal ulcerations and inflammatory intestinal disease suggestive of Crohn’s disease.


GSDIb is inherited in an autosomal recessive manner. Veiga-da-Cunha et al.  identified variants in the SLC37A4 (solute carrier family 37, member 4) gene (also known as the G6PT1 gene) as the cause of GSDIb (Am J Hum Genet 63:976-983, 1998). It appears that most or all cases of GSD types 1c and 1d are allelic with GSD1b and are caused by variants in SLC37A4 (Veiga-da-Cunha et al. Eur J Hum Genet 7:717-723, 1999). Approximately 80 different variants have been identified in SLC37A4 (Froissart and Maire. Orhpanet Encyclopedia 2002 (http://www.orpha.net/data/patho/GB/uk-glycogenosis1.pdf); Human Gene Mutation Database (http://www.hgmd.org/)). The variants are distributed throughout the length of the gene. Causative variants are missense, nonsense, splicing, frameshift, and rarely, large deletions.

Clinical Sensitivity - Sequencing with CNV PGxome

Based on literature reports, we estimate that our full gene sequencing test will detect likely causative variants in nearly all patients with GSDIb. Rarely (in perhaps 3% of patients), only one of the two variants will be detected.

Testing Strategy

This test provides full coverage of all coding exons of the SLC37A4 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).

Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).

Indications for Test

Candidates for this test are patients with symptoms consistent with GSDIb and the family members of patients who have known variants. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in SLC37A4.


Official Gene Symbol OMIM ID
SLC37A4 602671
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Related Tests

Glycogen Storage Disease Type Ia via the G6PC1/G6PC Gene
Glycogen Storage Disease Type III via the AGL Gene
Severe Congenital Neutropenia and Neutrophilia via the CSF3R Gene
Severe Congenital Neutropenia Panel


  • Human Gene Mutation Database (Bio-base).
  • Roseline Froissart, Ir?ne Maire (2002). "Glycogenosis type I or von Gierke?s disease.".
  • Veiga-da-Cunha, M., et.al. (1998). "A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic." Am J Hum Genet 63(4): 976-83. PubMed ID: 9758626
  • Veiga-da-Cunha, M., et.al. (1999). "The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a." Eur J Hum Genet 7(6): 717-23. PubMed ID: 10482962


Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.

Specimen Types

Specimen Requirements and Shipping Details

PGxome (Exome) Sequencing Panel

PGnome (Genome) Sequencing Panel

loading Loading... ×


An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)

1) Select Test Type

2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
Copy Text to Clipboard